Figure A3.27. Forest plot for high dose non-CLZ AAP versus std dose CLZ: Body weight (kg) (WMD of changes from baseline (95% CI)) — subgroup by drug.

Figure A3.27Forest plot for high dose non-CLZ AAP versus std dose CLZ: Body weight (kg) (WMD of changes from baseline (95% CI)) — subgroup by drug

From: APPENDIX 4, FOREST PLOTS FROM RANDOM EFFECTS META-ANALYSIS (REFERENCE CASE ANALYSES AND SUBGROUPS BY DRUG)

Cover of A Systematic Review of Combination and High-Dose Atypical Antipsychotic Therapy in Patients with Schizophrenia
A Systematic Review of Combination and High-Dose Atypical Antipsychotic Therapy in Patients with Schizophrenia [Internet].
CADTH Optimal Use Report, No. 1.1B.
Copyright © 2011 Canadian Agency for Drugs and Technologies in Health.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.